Search by Drug Name or NDC
NDC 24208-0505-15 Levobunolol Hydrochloride 5 mg/mL Details
Levobunolol Hydrochloride 5 mg/mL
Levobunolol Hydrochloride is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is LEVOBUNOLOL HYDROCHLORIDE.
MedlinePlus Drug Summary
Ophthalmic levobunolol is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Levobunolol is in a class of medications called beta blockers. It works by decreasing the pressure in the eye.
Related Packages: 24208-0505-15Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Levobunolol Ophthalmic
Product Information
NDC | 24208-0505 |
---|---|
Product ID | 24208-505_824dc29c-3ab9-4e52-9a4d-82ca578ee3b0 |
Associated GPIs | 86250020102005 |
GCN Sequence Number | 007858 |
GCN Sequence Number Description | levobunolol HCl DROPS 0.5 % OPHTHALMIC |
HIC3 | Q6G |
HIC3 Description | MIOTICS AND OTHER INTRAOCULAR PRESSURE REDUCERS |
GCN | 33310 |
HICL Sequence Number | 003459 |
HICL Sequence Number Description | LEVOBUNOLOL HCL |
Brand/Generic | Generic |
Proprietary Name | Levobunolol Hydrochloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Levobunolol Hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION/ DROPS |
Route | OPHTHALMIC |
Active Ingredient Strength | 5 |
Active Ingredient Units | mg/mL |
Substance Name | LEVOBUNOLOL HYDROCHLORIDE |
Labeler Name | Bausch & Lomb Incorporated |
Pharmaceutical Class | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA074326 |
Listing Certified Through | 2024-12-31 |
Package
NDC 24208-0505-15 (24208050515)
NDC Package Code | 24208-505-15 |
---|---|
Billing NDC | 24208050515 |
Package | 1 BOTTLE, DROPPER in 1 CARTON (24208-505-15) / 15 mL in 1 BOTTLE, DROPPER |
Marketing Start Date | 1994-03-04 |
NDC Exclude Flag | N |
Pricing Information | N/A |